Health and Medicine

The link between climate and cholera, a serious health problem in many parts of the world, has become stronger in recent decades, say researchers from the University of Michigan, the University of Barcelona and the International Center for Diarrhoeal Disease Research in Bangladesh.

Their research will be published in the online version of the Proceedings of the National Academy of Sciences this week.

In a previous study published in the journal Science, the researchers found eviden

Research on an AIDS-like disease in monkeys continues to help scientists understand problems such as how HIV causes AIDS, how the virus “hides” from the immune system and how the disease might be prevented or treated, two decades after the human and monkey diseases were identified.

“These animals have been indispensable for understanding how the virus works and in working toward vaccines,” said Murray Gardner, professor emeritus of medical pathology at the UC Davis Center for Comparative Me

Rush is one of only two sites in nation testing the drug that may provide new treatment option

Physicians at Rush-Presbyterian St. Luke’s Medical Center have begun to recruit patients as part of a clinical research study that will evaluate the effectiveness of a new drug as a potential treatment for fragile X syndrome and autism.

The trials are taking place at Rush and the University of California, Davis. The principal investigators in the study are Dr. Elizabeth Berry-Krav

Using transplants of bone marrow cells improved the recovery from stroke in rat experiments, according to a study published in the August 27 issue of Neurology, the scientific journal of the American Academy of Neurology.

The rats treated with an intravenous transplant of adult human stromal cells (mature cells from bone marrow) had significant improvements in their ability to function 14 days after the stroke, compared to rats that did not receive transplants after a stroke.

“The

Results of three studies presented today at the International Congress of The Transplantation Society provide encouraging evidence that a patient’s immune system can be fooled into accepting a transplanted organ without the need for anti-rejection drugs.

According to one study conducted in India, patients are off the immunosuppressive drug cyclosporine three months after undergoing living donor kidney transplantation and an elaborate set of treatments that included a separate surgical

Treating the skin with caffeine has been shown to prevent skin cancer in laboratory studies conducted in the Susan Lehman Cullman Laboratory for Cancer Research at Rutgers, The State University of New Jersey.

“It is not a sun-screening effect, but it’s something more than that – it’s a biological effect,” said Allan Conney, William M. and Myrle W. Garbe Professor of Cancer and Leukemia Research at Rutgers’ Ernest Mario School of Pharmacy. “We may have found a safe and effecti